Bristol Myers Squibb Company BMY

62.86 1.36 2.21% as of 25 Sep
Market cap
$125.9B
P/E
13.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Bristol Myers Squibb Company (BMY) Book value per share

Bristol Myers Squibb Company's book value per share at the end of fiscal 2025 was 9.1×, up 12.5% from 8.1× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 10.9×. Over the past ten years it has ranged from 7.2× (fiscal 2017) to 30.3× (fiscal 2019); the current reading is higher than 45% of that period. Bristol Myers Squibb Company ranks 12th of 21 Drug Manufacturers General companies by book value per share.

Book value per share, annual

Annual

Period Book value per share Change
FY2025 9.1× 12.53%
FY2024 8.1× (43.27%)
FY2023 14.3× (2.45%)
FY2022 14.6× (9.88%)
FY2021 16.2× (3.37%)
FY2020 16.8× (44.67%)
FY2019 30.3× 250.50%
FY2018 8.7× 20.12%
FY2017 7.2× (26.38%)
FY2016 9.8× 13.06%

Quarterly

Period Book value per share Change
Jun 2026 10.9× 10.81%
Mar 2026 9.9× 8.41%
Dec 2025 9.1× (0.41%)
Sep 2025 9.1× 6.30%
42 more quarters

Against its own ten years

Low 7.2× High 30.3×
Ten-year median 9.8×
Current reading's percentile 45

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on BMY